Monitoring guideline adherence in the management of acute coronary syndrome in hospitals: Design of a multicentre study

Netherlands Heart Journal

Volumn 22, Issue 7-8, 2014, Pages 346-353

  Tra, J ^a   Engel, J ^a   van der Wulp, I ^a   de Bruijne, M C ^a   Wagner, C ^b  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NETHERLANDS INSTITUTE FOR HEALTH SERVICES RESEARCH   (Netherlands)

Author keywords

Acute coronary syndrome; Acute coronary syndrome drug therapy; Methods; Quality indicator; Risk assessment; Study protocol; Time to treatment

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; THIENOPYRIDINE DERIVATIVE;

ACUTE CORONARY SYNDROME; AGED; ARTICLE; CARDIOVASCULAR MORTALITY; CROSS-SECTIONAL STUDY; FEMALE; HEART FAILURE; HOSPITAL DISCHARGE; HOSPITAL SERVICE; HUMAN; MALE; MEDICATION THERAPY MANAGEMENT; PRACTICE GUIDELINE; RETROSPECTIVE STUDY; RISK ASSESSMENT; SCORING SYSTEM; SECONDARY PREVENTION; TREATMENT OUTCOME;

EID: 84904561394     PISSN: 15685888     EISSN: 18766250     Source Type: Journal    
DOI: 10.1007/s12471-014-0574-4     Document Type: Article

References (35)

1. Allen LA, O'Donnell CJ, Camargo CA, et al. Comparison of longterm mortality across the spectrum of acute coronary syndromes. Am Heart J. 2006;151(5):1065-71.
2. Liebson PR, Klein LW. The non-Q wave myocardial infarction revisited: 10 years later. Prog Cardiovasc Dis. 1997;39(5):399-444.
3. Canto AJ, Kiefe CI, Goldberg RJ, et al. Differences in symptom presentation and hospital mortality according to type of acute myocardial infarction. Am Heart J. 2012;163(4):572-9.
4. Fox KA, Steg PG, Eagle KA, et al. Decline in rates of death and heart failure in acute coronary syndromes, 1999-2006. JAMA. 2007;297(17):1892-900.
5. Jernberg T, Johanson P, Held C, et al. Association between adoption of evidence-based treatment and survival for patients with STelevation myocardial infarction. JAMA. 2011;305(16):1677-84.
6. Mandelzweig L, Battler A, Boyko V, et al. The second Euro Heart Survey on acute coronary syndromes: characteristics, treatment, and outcome of patients with ACS in Europe and the Mediterranean Basin in 2004. Eur Heart J. 2006;27(19):2285-93.
7. Cannon CP, Gibson CM, Lambrew CT, et al. Relationship of symptom-onset-to-balloon time and door-to-balloon time with mortality in patients undergoing angioplasty for acute myocardial infarction. JAMA. 2000;283(22):2941-7.
8. Boersma E, Pieper KS, Steyerberg EW, et al. Predictors of outcome in patients with acute coronary syndromes without persistent STsegment elevation: results from an international trial of 9461 patients. Circulation. 2000;101(22):2557-67.
9. Braunwald E, Mark DB, Jones RH, et al. Unstable angina: diagnosis and management. Clinical practice guideline number 10, publication 94-0602. Rockville, MD: Agency for Health Care Policy and Research and the National Heart, Lung, and Blood Institute, US Public Health Service, US Department of Health and Human Services; 1994.
10. Peterson ED, Roe MT, Mulgund J, et al. Association between hospital process performance and outcomes among patients with acute coronary syndromes. JAMA. 2006;295(16):1912-20.
11. Lahoud R, Howe M, Krishnan SM, et al. Effect of use of combination evidence-based medical therapy after acute coronary syndromes on long-term outcomes. Am J Cardiol. 2012;109(2):159-64.
12. Hamm CW, Bassand JP, Agewall S, et al. ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J. 2011;32(23):2999-3054.
13. Steg PG, James SK, Atar D, et al. ESC Guidelines for the management of acute myocardial infarction in patients presenting with STsegment elevation. Eur Heart J. 2012;33(20):2569-619.
14. Boyer NM, Laskey WK, Cox M, et al. Trends in clinical, demographic, and biochemical characteristics of patients with acute myocardial infarction from 2003 to 2008: a report from the American Heart Association Get With The Guidelines coronary artery disease program. J Am Heart Assoc. 2012;1(4):e001206.
15. Terkelsen CJ, Sørensen JT, Maeng M, et al. System delay and mortality among patients with STEMI treated with primary percutaneous coronary intervention. JAMA. 2010;304(7):763-71.
16. Yan AT, Yan RT, Tan M, et al. Optimal medical therapy at discharge in patients with acute coronary syndromes: temporal changes, characteristics, and 1-year outcome. Am Heart J. 2007;154(6):1108-15.
17. VMS veiligheidsprogramma [VMS safety management program] [Internet] 2013. Available from:www.vmszorg.nl.
18. Granger CB, Goldberg RJ, Dabbous O, et al. Predictors of hospital mortality in the global registry of acute coronary events. Arch Intern Med. 2003;163(19):2345-53.
19. Fox KA, Dabbous OH, Goldberg RJ, et al. Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE). BMJ. 2006;333(7578):1091.
20. Antman EM, Cohen M, Bernink PJLM, et al. The TIMI risk score for unstable angina/non-ST elevation MI: a method for prognostic and therapeutic decision making. JAMA. 2000;284(7):835-42.
21. Lagerqvist B, Diderholm E, Lindahl B, et al. FRISC score for selection of patients for an early invasive treatment strategy in unstable coronary artery disease. Heart. 2005;91(8):1047-52.
22. Six A, Backus B, Kelder J. Chest pain in the emergency room: value of the HEART score. Neth Heart J. 2008;16(6):191-6
23. Dutch Health Insurance Counsil. Pharmacotherapeutic Compass. 2012 [updated 2012 Jan 1]. Available from:http://www.fk.cvz.nl/.
24. Rubin DB. Inference and missing data. Biometrika. 1976;63(3):581-92.
25. Van Buuren S, Groothuis-Oudshoorn K. Mice: Multivariate Imputation by Chained Equations in R. J Stat Softw. 2011;45(3):1-67.
26. Galbraith S, Daniel JA, Vissel B. A study of clustered data and approaches to its analysis. J Neurosci. 2010;30(32):10601-8.
27. Maas CJM, Hox JJ. Sufficient sample sizes for multilevel modeling. Methodology. 2005;1(3):86-92.
28. Bradley EH, Herrin J, Wang Y, et al. Strategies for reducing the doorto-balloon time in acute myocardial infarction. N Engl J Med. 2006;355(22):2308-20.
29. Bradley EH, Nallamothu BK, Herrin J, et al. National efforts to improve door-to-balloon time: results from the Door-to-Balloon Alliance. J Am Coll Cardiol. 2009;54(25):2423-9.
30. Cannon CP, Hoekstra JW, Larson DM, et al. A report of quality improvement in the care of patients with acute coronary syndromes. Crit Pathw Cardiol. 2011;10(1):29-34.
31. Peterson GM, Thompson A, Pulver LK, et al. Management of acute coronary syndromes at hospital discharge: do targeted educational interventions improve practice quality? J Healthc Qual. 2012;34(1):26-34.
32. O'Gara PT, Kushner FG, Ascheim DD, et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction. Circulation. 2013;127(4):529-55.
33. Jneid H, Anderson JL, Wright RS, et al. 2012 ACCF/AHA focused update of the guideline for the management of patients with unstable angina/non-ST-elevation myocardial infarction (updating the 2007 guideline and replacing the 2011 focused update). Circulation. 2012;126(7):875-910.
34. Chew DP, Aroney CN, Aylward PE, et al. 2011 addendum to the National Heart Foundation of Australia/Cardiac Society of Australia and New Zealand guidelines for the management of acute coronary syndromes (ACS) 2006. Heart Lung Circ. 2011;20(8):487-502.
35. De Blok C, Koster E, Schilp J, et al. Implementatie VMS veiligheidsprogramma [Implementation of the Dutch national patient safety program]. Utrecht: NIVEL and EMGO+Institute; 2013